News|Articles|October 23, 2023
FDA Approves First-of-its-Kind Subcutaneous Infliximab Biosimilar
Author(s)
Lauren MassaroNewly approved by the FDA, Celltrion’s infliximab-dyyb (Zymfentra) offers patients with inflammatory bowel disease a more innovative a... See more
